Wilhelmus A. Kersten
Parkville, VIC 3052, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase.
Journal: The Biochemical journal
Published: February 09, 2023
Potent Inhibition of Necroptosis by Simultaneously Targeting Multiple Effectors of the Pathway.
Journal: ACS chemical biology
Published: September 09, 2020
The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL.
Journal: Cell death & disease
Published: August 24, 2020
Viral MLKL Homologs Subvert Necroptotic Cell Death by Sequestering Cellular RIPK3.
Journal: Cell reports
Published: November 02, 2018
Structure-Guided Rescaffolding of Selective Antagonists of BCL-XL.
Journal: ACS medicinal chemistry letters
Published: January 22, 2014
Characterization of the novel broad-spectrum kinase inhibitor CTx-0294885 as an affinity reagent for mass spectrometry-based kinome profiling.
Journal: Journal of proteome research
Published: May 23, 2013
Structure-guided design of a selective BCL-X(L) inhibitor.
Journal: Nature chemical biology
Published: October 10, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026